Abstract The insulin-like growth factor (IGF-1) signalling is highly implicated in cancer
C., Fordyce, F
What Patients Should Know About Muscle Loss and GLP-1 Drugs Losing some muscle during GLP-1driven weight loss is normal, but it can be minimized
If you have a personal or family history of medullary thyroid cancer or MEN2 syndrome, a thorough discussion with your GP is mandatory, as these medications are usually contraindicated in those cases.
Reconstitution and storage considerations Compounded GLP-1 peptides require proper reconstitution and storage, and errors in either process could affect the drug's molecular integrity
Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, Bai R, Hainline B, Hamosh A, OBrien WE, Scaglia F, Wong LJ (2009) Citrin deficiency, a perplexing global disorder